How it may work
A prescription medicine and flavonoid combination studied experimentally for effects on senescent-cell pathways.
Guide-level evidence orientationEvidence level E
Level E marks a central question without dependable direct human evidence; read the outcome conclusion rather than treating the letter as a direction of effect.
This guide-level grade is an orientation, not a direction-of-effect label, product grade, claim or personal recommendation.Why people are interested
A medicine-plus-flavonoid combination studied for removing certain ageing cells. Human research is small and the medical risks are significant.
Library trackMedical research
Last reviewed20 Aug 2026
Guide scopeIngredient research only
What people have studied
Small early studies and active trials do not establish routine longevity use in healthy people.
What to consider
Dasatinib can cause serious adverse effects and requires specialist medical oversight; this is not a self-use protocol.
Local pathway
Experimental medical research only. Not offered or sold by CELLIVITY.
Sources + indexes
See where the explanation comes from.
Open the linked research and official records behind this guide. Early topics may begin with a research index while stronger sources are added.